After 60 sessions in 90 days, Bryan Johnson reports full-body rejuvenation, reduced inflammation, and biological age reversal with hyperbaric oxygen therapy. Today, Bryan Johnson revealed why...
Bryan Johnson shares data showing a 28 percent drop in p-TAU217, a newly FDA-approved marker for early Alzheimer’s risk, following hyperbaric oxygen therapy. Today, we’re sharing...
A closer look at Bryan Johnson’s precise hyperbaric oxygen therapy setup, designed to boost benefits while minimizing risk during his 90-day longevity experiment. Today, Bryan Johnson...
From pre-dawn routines to cutting-edge therapies, Bryan Johnson’s daily longevity protocol offers a glimpse into a future defined by health optimization and purpose. Today, Bryan Johnson...
